OPA1 and heart failure: Imbalanced OPA1 processing and mitochondrial fragmentation upon cardiac deletion of Yme1l are associated with cardiomyocyte death and heart failure, which can be suppressed by additional deletion of Oma1 (Wai et al, 2015).